EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Current practices and challenges in genetic testing and counseling for women with breast and ovarian cancer in Asia

Ava Kwong iD, David S-P Tan iD, Jai Min Ryu iD, ACROSS Consortium

Asia-Pacific Journal of Clinical Oncology · 2025

DOI: 10.1111/ajco.14074 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Asia-Pacific Journal of Clinical Oncology, 2025. Verfasst von Ava Kwong und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, School of Clinical Medicine, The University of Hong Kong, Hong Kong, Hong Kong. Hauptthemen laut MEDLINE: Specialties, Surgical, Hereditary Breast and Ovarian Cancer Syndrome, Genetic Testing, Genetic Counseling. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: AstraZeneca.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

This study assesses current practices and challenges in genetic testing and counseling (GT and C) for breast cancer gene ( BRCA )1/2 mutations in Asia, considering the increased risk of ovarian cancer (OC) and breast cancer (BC) in women carrying these mutations.

Methods

Insights were gathered through a questionnaire from breast surgeons, gynecologists, oncologists, and genetic clinicians in 10 Asian countries: Thailand, Hong Kong, South Korea, India, Vietnam, Malaysia, the Philippines, Taiwan, Singapore, and Indonesia. The questionnaire covered their knowledge, attitudes, and practices in GT and C for BRCA1/2 mutations, along with information on perceived gaps and unmet needs in the region.

Results

A total of 61 specialists participated in the survey. GT and C for BRCA1/2 mutations were less frequently offered in Asia compared to Western countries. Among the guidelines used, the National Comprehensive Cancer Network (NCCN) guidelines alone or in combination with other guidelines (American Society of Clinical Oncology [ASCO], National Institute for Health and Clinical Excellence [NICE], and European Society for Medical Oncology [ESMO]) were preferred for both BC and OC. Limited access to genetic counselors posed a significant challenge, resulting in delayed or no GT. Pretest genetic counseling was provided by the respondents themselves. Germline testing was preferred for BC, whereas both germline and somatic testing were preferred for OC, with the most preferred option being a multipanel germline test.

Conclusion

Disparities exist in GT and C practices between Asian and Western countries. To address this, steps, such as patient and doctor education, increased accessibility and affordability of GT and C services, and improved infrastructure for identifying gene mutations, should be taken.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Specialties, SurgicalHereditary Breast and Ovarian Cancer SyndromeGenetic TestingGenetic CounselingHealth Knowledge, Attitudes, PracticeSurveys and QuestionnairesCross-Sectional StudiesAttitude of Health PersonnelAsiaHumansBRCA1 ProteinBRCA2 Protein

Stichwörter der Autor:innen

Asiabreast neoplasmsgenetic counselinggenetic testingovarian neoplasms

Substanzen

BRCA1 protein, humanBRCA1 ProteinBRCA2 protein, humanBRCA2 Protein

Autor:innen und Institutionen

  • Department of Surgery, School of Clinical Medicine, The University of Hong Kong, Hong Kong, Hong Kong.
  • The Hong Kong Hereditary Breast Cancer Family Registry, Shau Kei Wan, Hong Kong.
  • Department of Surgery and Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong, Hong Kong.
  • Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore (NUS), Singapore, Singapore.
  • Department of Haematology-Oncology, National University Cancer Institute Singapore (NCIS), National University Hospital (NUH), Singapore, Singapore.
  • Division of Breast Surgery, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.

ORCID-Profile: Ava Kwong, David S-P Tan, Jai Min Ryu

Förderung

  • AstraZeneca

Zitieren

APA

Kwong, A., Tan, D. S., Ryu, J. M., & ACROSS Consortium (2025). Current practices and challenges in genetic testing and counseling for women with breast and ovarian cancer in Asia. Asia-Pacific Journal of Clinical Oncology. https://doi.org/10.1111/ajco.14074

Vancouver

Kwong A, Tan DS, Ryu JM, ACROSS Consortium. Current practices and challenges in genetic testing and counseling for women with breast and ovarian cancer in Asia. Asia-Pacific Journal of Clinical Oncology. 2025. doi:10.1111/ajco.14074

BibTeX
@article{Kwong2025,
  author = {Kwong, Ava and Tan, David S-P and Ryu, Jai Min and ACROSS Consortium, ACROSS Consortium},
  title = {Current practices and challenges in genetic testing and counseling for women with breast and ovarian cancer in Asia},
  journal = {Asia-Pacific Journal of Clinical Oncology},
  year = {2025},
  doi = {10.1111/ajco.14074}
}
Kostenlos starten →